Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Oct;42(4):516–523. doi: 10.1038/bjc.1980.274

Organ-related and malignancy-associated reactivity of cancer patients' leucocytes: a leucocyte migration study with tumour and foetal extracts.

S Matzku, M Zöller, U Ikinger, M R Price
PMCID: PMC2010430  PMID: 7437287

Abstract

Leucocytes from patients with a variety of tumours including gastric, colorectal, lung, kidney and mammary cancer, were tested in the leucocyte migration test (LMT) against organ-related and non-organ-related tumour and foetal extracts. The reactivity of cancer patients' leucocytes against a panel of organ-related tumour extracts was found to be 71-93%, depending on the tumour system tested. Cross-reactivity with a panel on non-organ-related tumour extracts was found in 0-38% of patients. Corresponding patterns of reactivity were obtained by testing patients' leucocytes against human foetal organ extracts; pathological migration indices (MI) were found in 70% of tests in which patients' leucocytes were reacted with organ-related extracts, and in 16% of tests with non-organ-related extracts. The data strongly support the concept that patients' leucocytes are sensitized to cross-reactive foetal determinants of organ-related specificities. Furthermore, it is proposed that foetal extracts as inducers of lymphokine production in presensitized lymphocytes could be used efficiently and reproducibly as a source of foetal antigen, as well as in the clinical application of the LMT procedure.

Full text

PDF
516

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black M. M., Zachrau R. E., Dion A. S., Shore B., Fine D. L., Leis H. P., Jr, Williams C. J. Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers. Cancer Res. 1976 Nov;36(11 Pt 1):4137–4142. [PubMed] [Google Scholar]
  2. Bloom E. T. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture. Cancer Res. 1972 May;32(5):960–967. [PubMed] [Google Scholar]
  3. Gorczynski R. M. Response of tumour-related and normal lymphocytes to antigens on fibroblasts from embryos of varying age. Br J Cancer. 1978 May;37(5):786–796. doi: 10.1038/bjc.1978.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kadish A. S., Marcus D. M., Bloom B. R. Inhibition of leukocyte migration by human breast-cancer-associated antigens. Int J Cancer. 1976 Nov 15;18(5):581–586. doi: 10.1002/ijc.2910180506. [DOI] [PubMed] [Google Scholar]
  5. Levin L., McHardy J. E., Curling O. M., Hudson C. N. Tumour antigenicity in ovarian cancer. Br J Cancer. 1975 Aug;32(2):152–159. doi: 10.1038/bjc.1975.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Marcussen H., Bendixen G. Circulating antibodies and leucocyte migration inhibition to colon-associated antigen in ulcerative colitis and Crohn's disease. Scand J Gastroenterol. 1974;9(2):149–152. [PubMed] [Google Scholar]
  7. Martin S. E., Martin W. J. Anti-tumour antibodies in normal mouse sera. Int J Cancer. 1975 Apr 15;15(4):658–664. doi: 10.1002/ijc.2910150415. [DOI] [PubMed] [Google Scholar]
  8. McCoy J. L., Jerome L. F., Cannon G. B., Weese J. L., Herberman R. B. Reactivity of lung cancer patients in leukocyte migration inhibition assays to 3-M potassium chloride extracts of fresh tumor and tissue-cultured cells derived from lung cancer. J Natl Cancer Inst. 1977 Nov;59(5):1413–1418. doi: 10.1093/jnci/59.5.1413. [DOI] [PubMed] [Google Scholar]
  9. Morton D. L. Immunological studies with human neoplasms. J Reticuloendothel Soc. 1971 Jul;10(1):137–160. [PubMed] [Google Scholar]
  10. Pierotti M. A., Colnaghi M. I. Natural antibodies directed against murine lymphosarcoma cells: variability of level in individual mice. Int J Cancer. 1976 Aug 15;18(2):223–229. doi: 10.1002/ijc.2910180212. [DOI] [PubMed] [Google Scholar]
  11. Reisfeld R. A., Kahan B. D. Biological and chemical characterization of human histocompatibility antigens. Fed Proc. 1970 Nov-Dec;29(6):2034–2040. [PubMed] [Google Scholar]
  12. Rosenberg S. A. Lysis of human normal and sarcoma cells in tissue culture by normal human serum: implications for experiments in human tumor immunology. J Natl Cancer Inst. 1977 May;58(5):1233–1238. doi: 10.1093/jnci/58.5.1233. [DOI] [PubMed] [Google Scholar]
  13. Weisbart R. H., Bluestone R., Goldberg L. S., Pearson C. M. Migration enhancement factor: a new lymphokine. Proc Natl Acad Sci U S A. 1974 Mar;71(3):875–879. doi: 10.1073/pnas.71.3.875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wells S. A., Jr, Burdick J. F., Christiansen C., Ketcham A. S., Adkins P. C. Demonstration of tumor-associated delayed cutaneous hypersensitivity reactions in patients with lung cancer and in pateients with carcinoma of the cervix. Natl Cancer Inst Monogr. 1973 Jun;37:197–203. [PubMed] [Google Scholar]
  15. Zöller M., Matzku S., Schulz U. Leukocyte migration studies in gastric cancer detection: an approach toward improved specificity and sensitivity. J Natl Cancer Inst. 1977 Apr;58(4):897–904. doi: 10.1093/jnci/58.4.897. [DOI] [PubMed] [Google Scholar]
  16. Zöller M., Matzku S., Schulz U., Price M. R. Sensitization of leukocytes of cancer patients against fetal antigens: leukocyte migration studies. J Natl Cancer Inst. 1979 Aug;63(2):285–293. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES